Jukema JW - Search Results

1

Therapeutic effects of FGF21 mimetic bFKB1 on MASH and atherosclerosis in Ldlr-/-.Leiden mice.

Inia JA, Attema J, de Ruiter C, Menke AL, Caspers MPM, Verschuren L, Wilson M, Arlantico A, Brightbill HD, Jukema JW, van den Hoek AM, Princen HMG, Chen MZ, Morrison MC. Inia JA, et al. Among authors: jukema jw. FASEB J. 2024 Oct 31;38(20):e70087. doi: 10.1096/fj.202401397R. FASEB J. 2024. PMID: 39463193 Free PMC article.

2

Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice.

Delsing DJ, Offerman EH, van Duyvenvoorde W, van Der Boom H, de Wit EC, Gijbels MJ, van Der Laarse A, Jukema JW, Havekes LM, Princen HM. Delsing DJ, et al. Among authors: jukema jw. Circulation. 2001 Apr 3;103(13):1778-86. doi: 10.1161/01.cir.103.13.1778. Circulation. 2001. PMID: 11282910

3

Raman spectroscopic evaluation of the effects of diet and lipid-lowering therapy on atherosclerotic plaque development in mice.

van De Poll SW, Römer TJ, Volger OL, Delsing DJ, Bakker Schut TC, Princen HM, Havekes LM, Jukema JW, van Der Laarse A, Puppels GJ. van De Poll SW, et al. Among authors: jukema jw. Arterioscler Thromb Vasc Biol. 2001 Oct;21(10):1630-5. doi: 10.1161/hq1001.096651. Arterioscler Thromb Vasc Biol. 2001. PMID: 11597937

4

Raman spectroscopic investigation of atorvastatin, amlodipine, and both on atherosclerotic plaque development in APOE*3 Leiden transgenic mice.

van de Poll SW, Delsing DJ, Jukema JW, Princen HM, Havekes LM, Puppels GJ, van der Laarse A. van de Poll SW, et al. Among authors: jukema jw. Atherosclerosis. 2002 Sep;164(1):65-71. doi: 10.1016/s0021-9150(02)00055-2. Atherosclerosis. 2002. PMID: 12119194

5

Differential effects of amlodipine and atorvastatin treatment and their combination on atherosclerosis in ApoE*3-Leiden transgenic mice.

Delsing DJ, Jukema JW, van de Wiel MA, Emeis JJ, van der Laarse A, Havekes LM, Princen HM. Delsing DJ, et al. Among authors: jukema jw. J Cardiovasc Pharmacol. 2003 Jul;42(1):63-70. doi: 10.1097/00005344-200307000-00010. J Cardiovasc Pharmacol. 2003. PMID: 12827028

6

Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: evidence for antiinflammatory effects of rosuvastatin.

Kleemann R, Princen HM, Emeis JJ, Jukema JW, Fontijn RD, Horrevoets AJ, Kooistra T, Havekes LM. Kleemann R, et al. Among authors: jukema jw. Circulation. 2003 Sep 16;108(11):1368-74. doi: 10.1161/01.CIR.0000086460.55494.AF. Epub 2003 Aug 25. Circulation. 2003. PMID: 12939225

7

Hepatic low-density lipoprotein receptor-related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol.

Espirito Santo SM, Pires NM, Boesten LS, Gerritsen G, Bovenschen N, van Dijk KW, Jukema JW, Princen HM, Bensadoun A, Li WP, Herz J, Havekes LM, van Vlijmen BJ. Espirito Santo SM, et al. Among authors: jukema jw. Blood. 2004 May 15;103(10):3777-82. doi: 10.1182/blood-2003-11-4051. Epub 2004 Jan 22. Blood. 2004. PMID: 14739216 Free article.

8

Genetic variation in the rate-limiting enzyme in cholesterol catabolism (cholesterol 7alpha-hydroxylase) influences the progression of atherosclerosis and risk of new clinical events.

Hofman MK, Princen HM, Zwinderman AH, Jukema JW. Hofman MK, et al. Among authors: jukema jw. Clin Sci (Lond). 2005 Jun;108(6):539-45. doi: 10.1042/CS20040339. Clin Sci (Lond). 2005. PMID: 15707388 Clinical Trial.

9

No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice.

Trion A, de Maat MP, Jukema JW, van der Laarse A, Maas MC, Offerman EH, Havekes LM, Szalai AJ, Princen HM, Emeis JJ. Trion A, et al. Among authors: jukema jw. Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):1635-40. doi: 10.1161/01.ATV.0000171992.36710.1e. Epub 2005 May 26. Arterioscler Thromb Vasc Biol. 2005. PMID: 15920036

10

Tumor necrosis factor-alpha plays an important role in restenosis development.

Monraats PS, Pires NM, Schepers A, Agema WR, Boesten LS, de Vries MR, Zwinderman AH, de Maat MP, Doevendans PA, de Winter RJ, Tio RA, Waltenberger J, 't Hart LM, Frants RR, Quax PH, van Vlijmen BJ, Havekes LM, van der Laarse A, van der Wall EE, Jukema JW. Monraats PS, et al. Among authors: jukema jw. FASEB J. 2005 Dec;19(14):1998-2004. doi: 10.1096/fj.05-4634com. FASEB J. 2005. PMID: 16319143

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,132 results

Search Page

Filters